BRIEF-Aethlon Medical received formal receipt from FDA for expedited access pathway program submission ‍​
Aug 14 (Reuters) - Aethlon Medical Inc:
* On Aug 14, co received formal receipt from the U.S. FDA for expedited access pathway program submission ‍​
* Submission formally requests that the Aethlon Hemopurifier be included in the FDA EAP program - SEC filing‍​ Source text: (bit.ly/2uIjrkU) Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)